Medium materiality6/10
AxoGen, Inc. (AXGN) PT Lowered to $53 at Truist Securities
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist lowers AXGN target to $53; current price $41.92; still upside implied.
- Target lowered to $53; price $41.92; Truist.
Key facts
- 01
Target: $53
- 02
Posted price: $41.92
- 03
Analyst firm: Truist Financial
- 04
Analyst: Ravi Misra
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.